About us

ADP works to ensure that people in low- and middle-income countries have access to life-saving health technologies – medicines, vaccines and diagnostic tools – with an emphasis on those technologies that address tuberculosis, malaria and neglected tropical diseases.

The partners

ADP brings together the United Nations Development Programme (UNDP), the World Health Organization (WHO), the Special Programme for Research and Training in Tropical Diseases (TDR) and PATH in a unique partnership that helps identify and strengthen capacity gaps in low- and middle-income countries in an innovative and integrated way.

Strengthening national health systems

In line with the overarching approach of the 2030 Agenda for Sustainable Development, ADP adopts a systemic and integrated perspective towards health system strengthening, aimed at the interlinked targets of eliminating communicable and infectious diseases and achieving real progress towards universal health coverage.

Supporting national responses to COVID-19

The COVID-19 pandemic has highlighted the critical importance of ensuring equitable access to health services, as well as increasing availability of medicines, vaccines and diagnostic tools in response to established and emerging health threats.

Regional, global and
South-South cooperation

Focusing on common challenges across different health systems, ADP leverages the experiences and expertise of its network of stakeholders to deliver both policy lessons and technical solutions.

Focus countries

ADP collaborates with stakeholders in a number of focus countries – Bhutan, Burkina Faso, Ghana, India, Indonesia, Malawi, Senegal, United Republic of Tanzania and Thailand
– to implement a range of capacity-strengthening interventions, which are in line with the ADP strategic approach of leveraging the expertise of its four core partners and working across sectors to help strengthen and harmonize policies, regulations and systems, as well as build the capacities of key people and institutions.

Uniting Efforts

The global response to the COVID-19 pandemic has highlighted how close collaboration among multiple stakeholders can overcome major hurdles to the development, approval and delivery of new medicines, vaccines and diagnostic tools. But opportunities for such intense collaboration are rare, and access to new health technologies remains uneven.

Knowledge products

ADP knowledge products advance learning and contribute to improved policies, programmes and practices, as well as demonstrate human impact on the ground.

TDR Implementation research toolkit

This toolkit is designed to help teams conduct implementation research projects through a standard process to ensure reliable, high-quality results.

COVID-19 diagnostics procurement resource

An interactive tool to support procurement decisions by aggregating and streamlining publicly available information about the technical specifications, regulatory status and supply of COVID-19 diagnostic tests.

A pipeline analysis of new products for malaria, tuberculosis and neglected tropical diseases

This working paper provides a comprehensive survey of new medicines, diagnostics and vaccines for malaria, TB and selected NTDs, that are currently in the pipeline for market entry by 2020.

Digital Health for Development Hub

A one-stop shop with technical, advisory and partnership support for scaling up digital health solutions.

News

Tanzania launches new partnership on Neglected Tropical Diseases

Posted March 07, 2014 By ADP

Cover photo: Dr. Neema Rusibamayila of the Ministry of Health and Social Welfare and Mr. Titus Osundina (Officer in charge), UNDP .

On 6 March 2014 Tanzania launched a new initiative to increase access and delivery of health technologies for tuberculosis (TB), malaria and neglected tropical diseases (NTDs). The initiative known as the “Access and Delivery Partnership” was launched by the Dr. Neema Rusibamayila (Acting Director of Preventive Services) on behalf of the Chief Medical Officer of the Ministry of Health and Social Welfare in the presence of 30 policy makers representing the Ministries of Health and Social Welfare, Finance, Communications, Science and Technology, Trade and Industry and the Prime Minister’s Office Regional Authority and Local Government, representatives of USAID, JSI and private sector. The two day inception and project planning workshop which culminated in the launch of the initiative was organized by UNDP, the World Health Organisation Special Programme for Research and Training in Tropical Diseases (TDR), and the Programme for Appropriate Technologies in Health (PATH) under the leadership of the Ministry of Health and Social Welfare of Tanzania.

The regional initiative seeks to leverage expertise to provide the full range of technical skills necessary to strengthen capacity in low-and middle-income countries (LMICs). The three development organizations within the partnership will be strengthening health system capacities to absorb new health technologies for TB, malaria and NTDs. The five key outputs of the project include:

coherent policy and legal frameworks;
enhanced capacity for evaluation of epidemiological studies to identify country specific needs;
strengthened health sector capacity for monitoring of Phase IV clinical trials;
improved capacity to ensure sustainable financing, and developed capacity for commercialization to ensure appropriate pricing and adequate supply; and
enhanced capacity in supply chain and delivery systems.

In consultation with the policy makers in Tanzania, the project will work towards identifying and addressing bottlenecks within the health system to strengthen the capacity of key government and non-governmental stakeholders to introduce new health technologies. Speaking at the close of the workshop Dr. Neema of the Ministry of Health and Social Welfare noted that the project fits in line with the Strategic Master Plan for the Neglected Tropical Diseases Control Programme and that “the capacity building and strengthening activities will prove to be important interventions which will have a positive influence on the Government’s health programming”.

Back to news